Keywords: new, data, sb, hycamtin, sclc, trials, smithkline

New Data With SB's Hycamtin In SCLC

Article | 22 August 1997

Print This

New data from three trials of SmithKline Beecham's topoisomerase Iinhibitor Hycamtin (topotecan) in the treatment of small cell lung cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in